BI/OND

BI/OND’s customizable Organ-on-Chips are built to outperform the limitation of standard in vitro assays. Through advanced and customizable solutions, BI/OND reproduces dynamic cell environments for biologists that demand nothing less.

BI/OND’s customizable Organ-on-Chips (OOCs) are built to outperform the limitation of standard in vitro assays.

Through advanced and customizable solutions, BI/OND reproduces dynamic cell culture environments for biologists that demand nothing less. BI/OND empowers biologists with hardware solutions for cell-based assays. BI/OND’s customizable Organ-on-Chips (OOCs) are built to outperform the limitation of standard in vitro assays. In the early phase of drug testing, petri dishes and animals can fall short of predicting what happens inside the human body.  To achieve accurate disease models and thus better medicine, it is fundamental to recreate human physiology and pathology. BI/OND offers unique hardware solutions for OOC applications that can be used to achieve this goal.

Silicon and polymers combined

BI/OND’s products are based on silicon, the same material that the “brain” of your computer or phone is made of. The combination of silicon with polymers, know-how developed over the past 5 years, makes our platform unique and extremely versatile for OOC applications.  In fact, through our advanced and customizable solutions, we reproduce dynamic cell environments for biologists that demand nothing less. Moreover, our young and enthusiastic team is here to develop and experiment with new technologies together with our customers.

Company Profile
Incorporation November 2017
Participation since November 2017
Team Cinzia Silvestri
Nikolas Gaio
William Quiros Solano
Linked faculty Faculty of Electrical Engineering, Mathematics & Computer Science
Website www.gobiond.com

 

Company history and milestones
July 2016 Patent Filed
August 2016 Received Nanonext Valorisation Grant
December 2016 Participated in Lifesciences@Work Venture Challenge
July 2017 Received NWO-TTW Take-off 1
November 2017 Incorporation BIOND Solutions B.V.
January 2018 Awarded with the EIT Health Proof of Concept funding